Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize th...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3629257?pdf=render |
id |
doaj-127707baa5244c649f79ec815983e29b |
---|---|
record_format |
Article |
spelling |
doaj-127707baa5244c649f79ec815983e29b2020-11-24T21:17:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6181710.1371/journal.pone.0061817Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.Anders TisellOlof Dahlqvist LeinhardJan Bertus Marcel WarntjesAnne AaltoÖrjan SmedbyAnne-Marie LandtblomPeter LundbergIn Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize the NAWM and thalamus both in atypical 'Clinically Definite MS' (CDMS) patients, MRI(neg) (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRI(pos) (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using 'Multiple Sclerosis Severity Score' (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRI(neg) 8.12 mM, p<0.001 and MRI(pos) 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16 ± 0.06 mM/MSSS (p = 0.02) for Glx and 0.06 ± 0.03 mM/MSSS (p = 0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were -6.22 ± 1.63 mM/BPF (p<0.001) for tCr and -7.71 ± 2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRI(pos) patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p = 0.04 mIns p<0.001) and MRI(neg) (tNA: p = 0.03 , mIns: p = 0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions.http://europepmc.org/articles/PMC3629257?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anders Tisell Olof Dahlqvist Leinhard Jan Bertus Marcel Warntjes Anne Aalto Örjan Smedby Anne-Marie Landtblom Peter Lundberg |
spellingShingle |
Anders Tisell Olof Dahlqvist Leinhard Jan Bertus Marcel Warntjes Anne Aalto Örjan Smedby Anne-Marie Landtblom Peter Lundberg Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. PLoS ONE |
author_facet |
Anders Tisell Olof Dahlqvist Leinhard Jan Bertus Marcel Warntjes Anne Aalto Örjan Smedby Anne-Marie Landtblom Peter Lundberg |
author_sort |
Anders Tisell |
title |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. |
title_short |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. |
title_full |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. |
title_fullStr |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. |
title_full_unstemmed |
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. |
title_sort |
increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal mr imaging brain scans. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton 'Quantitative Magnetic Resonance Spectroscopy' (qMRS) to characterize the NAWM and thalamus both in atypical 'Clinically Definite MS' (CDMS) patients, MRI(neg) (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRI(pos) (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using 'Multiple Sclerosis Severity Score' (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRI(neg) 8.12 mM, p<0.001 and MRI(pos) 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16 ± 0.06 mM/MSSS (p = 0.02) for Glx and 0.06 ± 0.03 mM/MSSS (p = 0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were -6.22 ± 1.63 mM/BPF (p<0.001) for tCr and -7.71 ± 2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRI(pos) patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p = 0.04 mIns p<0.001) and MRI(neg) (tNA: p = 0.03 , mIns: p = 0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions. |
url |
http://europepmc.org/articles/PMC3629257?pdf=render |
work_keys_str_mv |
AT anderstisell increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT olofdahlqvistleinhard increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT janbertusmarcelwarntjes increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT anneaalto increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT orjansmedby increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT annemarielandtblom increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans AT peterlundberg increasedconcentrationsofglutamateandglutamineinnormalappearingwhitematterofpatientswithmultiplesclerosisandnormalmrimagingbrainscans |
_version_ |
1726011533734969344 |